AI-driven Consulting And Transformation Will Open Financial And Health Opportunities

Published
06 Aug 24
Updated
06 Aug 25
AnalystConsensusTarget's Fair Value
US$87.91
21.3% undervalued intrinsic discount
06 Aug
US$69.15
Loading
1Y
-5.5%
7D
-3.0%

Author's Valuation

US$87.9

21.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Decreased 0.13%

Shared on30 Apr 25
Fair value Decreased 0.89%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Increased 1.48%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 0.35%

Shared on09 Apr 25
Fair value Decreased 3.49%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 2.14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 1.40%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 1.43%

AnalystConsensusTarget has decreased revenue growth from 7.7% to 5.6% and increased future PE multiple from 16.8x to 18.8x.